Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review

Background: Radiotherapy is a mainstay in head and neck squamous cell carcinoma (HNSCC) treatment but is mostly applied without stratification by molecular diagnostics. Development of reliable biomarkers may have the potential to improve radiotherapy (RT) efficacy and reduce toxicity. We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schanne, Daniel H., Koch, Alexander, Elicin, Olgun, Giger, Roland, Medová, Michaela, Zimmer, Yitzhak, Aebersold, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775486/
https://www.ncbi.nlm.nih.gov/pubmed/36552043
http://dx.doi.org/10.3390/biomedicines10123288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775486/
https://www.ncbi.nlm.nih.gov/pubmed/36552043
http://dx.doi.org/10.3390/biomedicines10123288

Ejemplares similares